Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Merck & Co Inc reaffirms FY 2014 revenue guidance; raises low end of prior FY 2014 EPS guidance to a range in line with analysts' estimates

Tuesday, 29 Jul 2014 06:56am EDT 

Merck & Co Inc:Expects FY 2014 non-GAAP EPS to be between $3.43 and $3.53, which excludes the potential impact of a Venezuelan Bolivar devaluation that was previously included in the range.Expects FY 2014 GAAP EPS to be between $4.44 and $4.77.Continues to expect FY 2014 revenues to be between $42.4 billion and $43.2 billion.FY 2014 EPS of $3.48 and revenue of $42.6 bln - Thomson Reuters I/B/E/S. 

Company Quote

1.12 +2.02%
23 Oct 2014